Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Circulation Research|June 20, 2019
15-Deoxy-Δ12,14-Prostaglandin J2 Reinforces the Anti-Inflammatory Capacity of Endothelial Cells With a Genetically Determined NO DeficitIvelina Urban, Martin Turinsky, Sviatlana Gehrmann, et al.
Drug Design, Development and Therapy|September 24, 2014
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimenMatthias Helmschrott, Jan Beckendorf, Ceylan Akyol, et al.
Innate Immunity|March 26, 2014
CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivoChristian Erbel, Mirjam Tyka, Christian M Helmes, et al.
Drug Design, Development and Therapy|March 12, 2015
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantationMatthias Helmschrott, Rasmus Rivinius, Arjang Ruhparwar, et al.
Frontiers in Cardiovascular Medicine|March 31, 2022
Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential PathophysiologiesJona B Krohn, Y Nhi Nguyen, Mohammadreza Akhavanpoor, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 21, 2025
CXCL4-Induced PBMCs Modulate Vascular Extracellular Matrix via Wnt5a-Dependent Matrix Metalloproteinase-7 and Calcifying Extracellular Vesicle ReleaseJona B Krohn, Laurine Kristin Sprehe, Florian Sicklinger, et al.
British Journal of Clinical Pharmacology|November 21, 2013
Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysisCatherine Cornu, Christophe Dufays, Ségolène Gaillard, et al.
Drug Design, Development and Therapy|October 24, 2012
Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patientsAndreas O Doesch, Janika Repp, Nina Hofmann, et al.
Pageof 6